R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for ELITE-BTK Pivotal Trial – Endovascular Today
January 17, 2025—R3 Vascular Inc. recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK pivotal tr